RNLS and hypertensive disorder: The downregulation of renalase results in hypertension, albuminuria, mesangial hypertrophy, renal inflammation, and injury, whereas renalase administration mitigates high glucose-induced profibrotic gene expression, and p21 expression via the inhibition of ERK 1/2 signaling.